← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2017Last known activity
Jul 6, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 3 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Recent trials (7)
- NCT05579119Reponsible party - principal investigatorPhase 4Jul 6, 2022
- NCT05579119Overall official - principal investigatorPhase 4Jul 6, 2022
- NCT03892421Reponsible party - principal investigatorPhase 1/Phase 2Apr 5, 2018
- NCT03892421Overall official - principal investigatorPhase 1/Phase 2Apr 5, 2018
- NCT03892421Lead sponsorPhase 1/Phase 2Apr 5, 2018
- NCT03877120Reponsible party - principal investigatorPhase 4Nov 1, 2017
- NCT03877120Lead sponsorPhase 4Nov 1, 2017
Details
- Last known activity
- Jul 6, 2022